LENSAR IncNASDAQ:LNSR
- LAST PRICE3.1400
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots2.5200/ 40
- Ask / Lots3.9200/ 10
- Open / Previous Close0.0000 / 3.1400
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | LNSR |
|---|---|---|
| 09:48 ET | 100 | 3.135 |
| 09:59 ET | 100 | 3.1 |
| 10:14 ET | 186 | 3.0001 |
| 10:15 ET | 100 | 3.1105 |
| 10:37 ET | 300 | 3.13 |
| 10:39 ET | 100 | 3.15 |
| 10:42 ET | 400 | 3.13 |
| 10:44 ET | 1500 | 3.2799 |
| 10:46 ET | 100 | 3.26 |
| 10:53 ET | 1718 | 3.265 |
| 11:02 ET | 682 | 3.39 |
| 11:04 ET | 500 | 3.221 |
| 11:06 ET | 250 | 3.221 |
| 11:26 ET | 100 | 3.3173 |
| 12:05 ET | 135 | 3.31 |
| 12:12 ET | 196 | 3.333 |
| 01:06 ET | 100 | 3.25 |
| 01:08 ET | 3378 | 3.2178 |
| 01:10 ET | 200 | 3.25 |
| 01:12 ET | 200 | 3.25 |
| 01:14 ET | 100 | 3.25 |
| 01:15 ET | 300 | 3.25 |
| 01:17 ET | 1000 | 3.25 |
| 01:19 ET | 300 | 3.25 |
| 01:24 ET | 700 | 3.25 |
| 01:26 ET | 200 | 3.25 |
| 01:28 ET | 100 | 3.23 |
| 01:30 ET | 200 | 3.23 |
| 01:32 ET | 100 | 3.23 |
| 01:33 ET | 200 | 3.21 |
| 01:35 ET | 400 | 3.21 |
| 01:37 ET | 200 | 3.21 |
| 01:39 ET | 300 | 3.21 |
| 01:42 ET | 100 | 3.21 |
| 01:44 ET | 200 | 3.21 |
| 01:46 ET | 300 | 3.21 |
| 01:48 ET | 450 | 3.2436 |
| 01:50 ET | 200 | 3.21 |
| 01:51 ET | 200 | 3.21 |
| 01:53 ET | 200 | 3.21 |
| 01:55 ET | 200 | 3.21 |
| 01:57 ET | 200 | 3.21 |
| 02:00 ET | 300 | 3.21 |
| 02:02 ET | 500 | 3.21 |
| 02:04 ET | 100 | 3.21 |
| 02:06 ET | 1118 | 3.2421 |
| 02:08 ET | 1755 | 3.2 |
| 02:09 ET | 100 | 3.2 |
| 02:11 ET | 2200 | 3.21 |
| 02:13 ET | 100 | 3.21 |
| 02:15 ET | 1387 | 3.2 |
| 02:18 ET | 100 | 3.11 |
| 02:20 ET | 200 | 3.11 |
| 02:22 ET | 200 | 3.17 |
| 02:24 ET | 200 | 3.11 |
| 02:26 ET | 200 | 3.17 |
| 02:27 ET | 200 | 3.1 |
| 02:29 ET | 100 | 3.2399 |
| 03:09 ET | 716 | 3.1636 |
| 03:16 ET | 200 | 3.04 |
| 03:18 ET | 200 | 3.06 |
| 03:20 ET | 400 | 3.06 |
| 03:21 ET | 800 | 3.06 |
| 03:23 ET | 515 | 3.06 |
| 03:25 ET | 600 | 3.06 |
| 03:27 ET | 1500 | 3.12 |
| 03:30 ET | 2200 | 3.06 |
| 03:32 ET | 100 | 3.11 |
| 03:36 ET | 716 | 3.105 |
| 03:45 ET | 156 | 3.14 |
Apr 1, 2024
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 6:28PM ET on Monday Apr 01, 2024 by Dow Jones
6:28PM ET on Monday Apr 01, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
LENSAR Inc | 35.8M | -2.3x | --- |
Cytosorbents Corp | 41.8M | -1.3x | --- |
Bionano Genomics Inc | 41.2M | -0.1x | --- |
Dynatronics Corp | 2.7M | -0.4x | --- |
STRATA Skin Sciences Inc | 18.7M | -1.7x | --- |
Owlet Inc | 35.1M | -0.9x | --- |
Company Information
LENSAR, Inc. is a commercial-stage medical device company. The Company is focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its product portfolio consists of the LENSAR Laser System and ALLY Adaptive Cataract Treatment System (ALLY System) and its associated consumable components. The system incorporates a range of technologies designed to assist the surgeon in obtaining visual outcomes. The consumable portion of the system consists of a disposable patient interface device kit. The ALLY System is designed to combine its femtosecond laser technology features with enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room or in-office surgical suite. Its system is used across surgeons, hospital outpatient surgical facilities and ambulatory surgery centers.
Contact Information
- Headquarters
- 2800 Discovery Drive, Suite 100ORLANDO, FL, United States 32826
- Phone
- ---
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- William Link
- Chief Executive Officer, Director
- Nicholas Curtis
- Chief Financial Officer, Secretary
- Thomas Staab
- Chief Operating Officer
- Alan Connaughton
- Independent Director
- Thomas Ellis
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $35.8M |
|---|---|
Revenue (TTM) | $42.2M |
Shares Outstanding | 11.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.49 |
EPS | $-1.34 |
Book Value | $4.16 |
P/E Ratio | -2.3x |
Price/Sales (TTM) | 0.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -29.00% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
